BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37894929)

  • 1. Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software.
    Seregin AA; Smirnova LP; Dmitrieva EM; Zavialova MG; Simutkin GG; Ivanova SA
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.
    Song YR; Wu B; Yang YT; Chen J; Zhang LJ; Zhang ZW; Shi HY; Huang CL; Pan JX; Xie P
    Braz J Med Biol Res; 2015 Nov; 48(11):973-82. PubMed ID: 26375446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
    Rodrigues JE; Martinho A; Santos V; Santa C; Madeira N; Martins MJ; Pato CN; Macedo A; Manadas B
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The difference in serum proteomes in schizophrenia and bipolar disorder.
    Smirnova L; Seregin A; Boksha I; Dmitrieva E; Simutkin G; Kornetova E; Savushkina O; Letova A; Bokhan N; Ivanova S; Zgoda V
    BMC Genomics; 2019 Jul; 20(Suppl 7):535. PubMed ID: 31291891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallomics-based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients.
    de Souza Pessôa G; de Jesus JR; Balbuena TS; Arruda MAZ
    Rapid Commun Mass Spectrom; 2020 Sep; 34 Suppl 3():e8698. PubMed ID: 31837042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
    Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
    J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics strategies for bipolar disorder evaluation: From sample preparation to validation.
    de Jesus JR; Pessôa GS; Sussulini A; Martínez JLC; Arruda MAZ
    J Proteomics; 2016 Aug; 145():187-196. PubMed ID: 27113133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.
    Oraki Kohshour M; Kannaiyan NR; Falk AJ; Papiol S; Heilbronner U; Budde M; Kalman JL; Schulte EC; Rietschel M; Witt S; Forstner AJ; Heilmann-Heimbach S; Nöthen MM; Spitzer C; Malchow B; Müller T; Wiltfang J; Falkai P; Schmitt A; Rossner MJ; Nilsson P; Schulze TG
    Transl Psychiatry; 2022 Nov; 12(1):471. PubMed ID: 36351892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallomics studies of human blood serum from treated bipolar disorder patients.
    Sussulini A; Kratzin H; Jahn O; Banzato CE; Arruda MA; Becker JS
    Anal Chem; 2010 Jul; 82(13):5859-64. PubMed ID: 20536186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients.
    Santa Cruz EC; Zandonadi FDS; Fontes W; Sussulini A
    Biochim Biophys Acta Proteins Proteom; 2021 Aug; 1869(8):140657. PubMed ID: 33839315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
    Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
    Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder.
    Du Y; Dong JH; Chen L; Liu H; Zheng GE; Chen GY; Cheng Y
    Oxid Med Cell Longev; 2022; 2022():5717445. PubMed ID: 35047107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics.
    Ribeiro HC; Klassen A; Pedrini M; Carvalho MS; Rizzo LB; Noto MN; Zeni-Graiff M; Sethi S; Fonseca FAH; Tasic L; Hayashi MAF; Cordeiro Q; Brietzke E; Sussulini A
    Psychiatry Res; 2017 Dec; 258():268-273. PubMed ID: 28918859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations between clinical features of bipolar affective disorder and serum concentrations of ANKRD12 gene product, coagulation factor XIII, and cadherin 5].
    Seregin AA; Smirnova LP; Dmitrieva EM; Boksha IS; Savushkina OK; Simutkin GG; Ivanova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):137-142. PubMed ID: 36440791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions.
    de Jesus JR; Galazzi RM; de Lima TB; Banzato CEM; de Almeida Lima E Silva LF; de Rosalmeida Dantas C; Gozzo FC; Arruda MAZ
    Clin Biochem; 2017 Dec; 50(18):1118-1125. PubMed ID: 28662995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.